This study is looking at how different factors, including social ones, might affect how well Black and White patients with advanced or metastatic cancer respond to treatment and experience side effects. Researchers will collect information from patients about their health, social situations, and genetic makeup. They want to see if there are differences in how long Black and White patients live (overall survival) and if they develop nerve damage (peripheral neuropathy) from a type of chemotherapy called taxane. You can join if you are 18 or older, have advanced cancer, and are having molecular testing as part of your regular cancer care. The study is currently collecting information from patients.

Study design

This is an observational study, meaning researchers will collect information without giving new treatments. It plans to include about 10,600 participants.

What's involved

You would complete questionnaires about your social determinants of health and treatment side effects. This information will be collected along with your clinical and genomic data.

Compensation

Not stated in the trial record.

Follow-up

Your health will be followed for up to 5 years, or until you pass away, are lost to follow-up, or withdraw from the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.